<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="89156">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02063152</url>
  </required_header>
  <id_info>
    <org_study_id>201305072RINC</org_study_id>
    <nct_id>NCT02063152</nct_id>
  </id_info>
  <brief_title>102 Annual Pap Smear Screening Database Maintenance Project</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <authority>Taiwan: Department of Health</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to evaluate the subsequent cancer risks, including gynecological cancers
      and malignancies at other sites, after the detection of screening positives and the
      diagnosis for primary cervical cancer.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 1995</start_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>25 Years</target_duration>
  <primary_outcome>
    <measure>Time to the cancer diagnosis or the recurrence, the death, or the last date of follow-up, whichever came first</measure>
    <time_frame>up to 25 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300000</enrollment>
  <condition>Cancer</condition>
  <condition>Human Papillomavirus</condition>
  <arm_group>
    <arm_group_label>Entire Taiwan women</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Women attended screening and found abnormal results, and women who were diagnosed as
        cervical cancer were the main study population. Women who did not attend screening for at
        least 6 years were also included.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Citizens in Taiwan

          -  Women who attended screening, or who were diagnosed as cervical cancer

          -  Women who did not attend screening for at least 6 years

        Exclusion Criteria:

          -  Women died before the follow-up initiation

          -  Women who had received hysterectomy before the follow-up initiation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chi-An Chen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yun-Yuan Chen, PhD</last_name>
    <phone>+886 2 23910409</phone>
    <phone_ext>20</phone_ext>
    <email>b87801006@ntu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Taiwan Cervical Cancer Prevention Monitoring Center</name>
      <address>
        <city>Taipei</city>
        <zip>10055</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yun-Yuan Chen, PhD</last_name>
      <phone>+886 2 23910409</phone>
      <phone_ext>20</phone_ext>
      <email>b87801006@ntu.edu.tw</email>
    </contact>
    <investigator>
      <last_name>Chi-An Chen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 13, 2014</lastchanged_date>
  <firstreceived_date>February 10, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
